Pacemakers and internal cardioverter defibrillators in adult congenital heart disease

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11130%2F18%3A10427372" target="_blank" >RIV/00216208:11130/18:10427372 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00064203:_____/18:10427372

Výsledek na webu

<a href="https://doi.org/10.1016/B978-0-7020-6929-1.00019-8" target="_blank" >https://doi.org/10.1016/B978-0-7020-6929-1.00019-8</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/B978-0-7020-6929-1.00019-8" target="_blank" >10.1016/B978-0-7020-6929-1.00019-8</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Pacemakers and internal cardioverter defibrillators in adult congenital heart disease

Popis výsledku v původním jazyce

Survival of children with congenital heart disease (CHD) continues to improve in lockstep with advances in surgical and medical therapy, and more than 90% now reach adulthood. Despite the impressive anatomic repairs that are now achievable, even adults with fully repaired CHD cannot be regarded as having normal hearts, and many will be prone to arrhythmias. More and more will meet indications for implantable cardiac devices-pacemakers as definitive therapy for bradycardia, implantable cardioverter-defibrillators (ICDs) for ventricu-lar arrhythmias, and cardiac resynchronization devices for impaired myocardial function and dyssynchrony. However, device implantation in adults with CHD is fraught with unique technical and management challenges, as described in this chapter

Název v anglickém jazyce

Pacemakers and internal cardioverter defibrillators in adult congenital heart disease

Popis výsledku anglicky

Survival of children with congenital heart disease (CHD) continues to improve in lockstep with advances in surgical and medical therapy, and more than 90% now reach adulthood. Despite the impressive anatomic repairs that are now achievable, even adults with fully repaired CHD cannot be regarded as having normal hearts, and many will be prone to arrhythmias. More and more will meet indications for implantable cardiac devices-pacemakers as definitive therapy for bradycardia, implantable cardioverter-defibrillators (ICDs) for ventricu-lar arrhythmias, and cardiac resynchronization devices for impaired myocardial function and dyssynchrony. However, device implantation in adults with CHD is fraught with unique technical and management challenges, as described in this chapter

Druh

C - Kapitola v odborné knize

CEP obor

—

OECD FORD obor

30201 - Cardiac and Cardiovascular systems

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2018

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název knihy nebo sborníku

Diagnosis and Management of Adult Congenital Heart Disease: Third Edition

ISBN

978-0-7020-6929-1

Počet stran výsledku

21

Strana od-do

232-252

Počet stran knihy

736

Název nakladatele

Elsevier

Místo vydání

Philadelphia

Kód UT WoS kapitoly

—